Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.49 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.46 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | BRD4 | O60885 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL714527 | 1.00 | MAPT (0.59) | MAPTGAAESR2SLC18A3SRD5A1 | |
| SCHEMBL715591 | 1.00 | MAPT (0.59) | MAPTGAAESR2SLC18A3SRD5A1 | |
| Ethylene SCHEMBL27953915 | 0.96 | MAPT (0.55) | MAPTGAAESR2SLC18A3SRD5A1 | |
| Hydrochloric Acid SCHEMBL9482313 | 0.96 | MAPT (0.55) | MAPTGAAESR2SLC18A3SRD5A1 | |
| SCHEMBL2312546 | 0.94 | MAPT (0.57) | MAPTGAAESR2SLC18A3SRD5A1 | |
| SCHEMBL18980773 | 0.94 | MAPT (0.57) | MAPTGAAESR2SLC18A3SRD5A1 | |
| SCHEMBL31252385 | 0.92 | MAPT (0.55) | MAPTGAAESR2SLC18A3SRD5A1 | |
| SCHEMBL29683554 | 0.92 | MAPT (0.55) | MAPTGAAESR2SLC18A3SRD5A1 | |
| SCHEMBL3446977 | 0.92 | MAPT (0.55) | MAPTGAAESR2SLC18A3SRD5A1 | |
| SCHEMBL19524597 | 0.91 | MAPT (0.50) | MAPTGAAESR2SLC18A3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118763202-A | Silicon-based negative electrode, preparation method thereof and all-solid-state battery | 高能时代(深圳)新能源科技有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-104640827-B | Produce the method for phenol and/or cyclohexanone by cyclohexyl benzene | 埃克森美孚化学专利公司 | 2016-11-09 | — | — | CN | claimed |
| CN-103848722-B | Produce the method for phenol | EXXON CHEMICAL PATENTS INC. (US) | 2016-05-25 | — | — | CN | claimed |
| US-9272974-B2 | Process for producing phenol and/or cyclohexanone from cyclohexylbenzene | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-03-01 | — | — | US | claimed |
| US-20150251997-A1 | Process for Producing Phenol | EXXONMOBIL CHEMICAL PATENTS INC. | 2015-09-10 | — | — | US | claimed |
| US-20150203429-A1 | Process for Producing Phenol and/or Cyclohexanone from Cyclohexylbenzene | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-07-23 | — | — | US | claimed |
| EP-2895442-A1 | PROCESS FOR PRODUCING PHENOL AND/OR CYCLOHEXANONE FROM CYCLOHEXYLBENZENE | ExxonMobil Chemical Patents Inc. (US) | 2015-07-22 | — | — | EP | claimed |
| CN-104640827-A | Process for producing phenol and/or cyclohexanone from cyclohexylbenzene | EXXONMOBIL CHEM PATENTS INC | 2015-05-20 | — | — | CN | claimed |
| WO-2014088842-A1 | PROCESS FOR PRODUCING PHENOL | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-06-12 | — | — | WO | claimed |
| WO-2014043188-A1 | PROCESS FOR PRODUCING PHENOL AND/OR CYCLOHEXANONE FROM CYCLOHEXYLBENZENE | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-03-20 | — | — | WO | claimed |
| WO-2025206106-A1 | METHODS FOR PRODUCING 3-PHENYLCYCLOHEXENONE COMPOUND AND DERIVATIVE THEREOF | 住友化学株式会社 | 2025-10-02 | — | — | WO | disclosed |
| US-20250282735-A1 | BICYCLE COMPOUNDS AS TEAD INHIBITOR | DONG-A ST CO., LTD. (KR) | 2025-09-11 | — | — | US | disclosed |
| EP-4514780-A1 | BICYCLE COMPOUNDS AS TEAD INHIBITOR | Dong-A ST Co., Ltd. (KR) | 2025-03-05 | — | — | EP | disclosed |
| EP-2349560-B1 | POLYMER-SUPPORTED TRANSITION METAL CATALYST COMPLEXES AND METHODS OF USE | UNIV KANSAS (US) | 2025-01-22 | — | — | EP | disclosed |
| US-20240368001-A1 | SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2024-11-07 | — | — | US | disclosed |
| EP-0068557-B1 | HERBICIDAL COMPOSITIONS CONTAINING HETEROCYCLIC PENTALENES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1987-12-09 | — | — | EP | disclosed |
| US-4482740-A | HERBICIDES | NIPPON SODA COMPANY LIMITED (JP) | 1984-11-13 | — | — | US | disclosed |
| US-4482740-A | HERBICIDES | NIPPON SODA COMPANY LIMITED (JP) | 1984-11-13 | — | — | US | disclosed |
| EP-0068557-A1 | Herbicidal compositions containing heterocyclic pentalenes | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1983-01-05 | — | — | EP | disclosed |
| US-4187152-A | Extractive distillation for separating ketones and/or alcohols from phenol and/or cresol | ALLIED CHEMICAL CORPORATION (US) | 1980-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150251997-A1 | Process for Producing Phenol | HPD, CYP2E1, CYP1A1 | MAPT 4616/4885GAA 3259/4885ESR2 249/4885 |
| US-20250282735-A1 | BICYCLE COMPOUNDS AS TEAD INHIBITOR | TEAD1, TEAD2, TEAD3 | MAPT 34/4885GAA 1508/4885ESR2 4179/4885 |
| US-20150203429-A1 | Process for Producing Phenol and/or Cyclohexanone from Cyclohexylbenzene | HPD, CYP2J2, HAAO | MAPT 4777/4885GAA 2003/4885ESR2 757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.